|
New line of DNA and serum samples for Type II diabetes, hypertension and hyperlipidemia provide researchers access to clinically defined controls to validate biomedical research results
ControlMATCH is a new line of fully annotated control DNA and serum samples designed to help biomedical researchers efficiently validate new biomarkers and early stage clinical trial drug candidates. Leveraging BioServe's Global Repository of 600,000 human biological samples, ControlMATCH allows researchers to select and match control samples to the specific needs of their own DNA and/or serum-based studies.
ControlMATCH DNA and serum controls will initially cover type II diabetes, hypertension and hyperlipidemia, and extend to other disease states in early 2008.
ControlMATCH normal samples for type II diabetes, hypertension and hyperlipidemia are annotated with:
- body mass index (BMI)
- confirmed normal blood glucose levels
- confirmed normal blood pressure and cholesterol levels
- family history of health status
- ethnicity determined by data collected on three generations.
ControlMATCH therefore permits researchers to identify one-to-one matched controls for extended criteria such as age, gender, ethnicity, BMI, diet and a host of lifestyle factors. Furthermore, ControlMATCH includes clinically confirmed negative results enabling researchers to further confirm that their markers are valued against the correct set of controls.
For more information email samples@bioserve.com or call 301 470 3362.
BioServe can provide age, gender, and ethnicity matched normal control DNA and serum samples for your research.
Genotyping and Genomic Analysis
Once you have chosen from our diverse, annotated sample repository, BioServe can facilitate your research studies with our accurate, cost-effective genomic analysis services. We have years of experience and validated protocols that will ensure you get accurate results with quick delivery times. If you have a custom project that you don't see listed under our Services options, contact us at info@bioserve.com or +1 301-470-3362 to discuss, as we may be able to accommodate your needs. |
Xin Li Wang, a professor and director in the cardiothoracic research laboratory in the division of cardiothoracic surgery of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, commented, "We are engaged in landmark cardiothoracic studies that we hope will reveal the DNA aberrations in a few target genes responsible for thoracic aortic disease. Like any large epidemiological study, time is money and generating valid results as quickly as possible is a prerequisite for success."
"The faster a study is able to generate validated results, the higher the probability of achieving longer term program milestones. By providing us with ready made DNA samples stratified by age, ethnicity and smoking status, BioServe™'s ControlMATCH has proven to be an indispensable tool in accelerating our research," he added.
Find out more about Professor Wang |
